Phase III Copanlisib in Rituximab-refractory iNHL

Clinical trial NCT02369016 · COMPLETED

Trial details

NCT number: NCT02369016
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2015-09-22
Primary completion: 2022-10-26
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.